Kenneth Pienta, Chief Medical Officer at Cue Biopharma, Inc. (CUE), sold 2,720 shares at $15.07 ($41K) on 2021-01-20, disclosed to the SEC on 2021-02-18.
Scheduled sale ($41k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CUE | BUY | 2021-01-22 | $41K | — | Filing → |
| CUE | BUY | 2018-01-19 | $15K | — | Filing → |
| CRIS | BUY | 2013-11-08 | $44K | — | Filing → |